Stewart v. Quest Diagnostics Clinical Laboratories, Inc.
This text of Stewart v. Quest Diagnostics Clinical Laboratories, Inc. (Stewart v. Quest Diagnostics Clinical Laboratories, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
1 UNITED STATES DISTRICT COURT 2 SOUTHERN DISTRICT OF CALIFORNIA 3 Pamela STEWART, et al., individually Case No.: 19-cv-2043-AGS-DDL and on behalf of all similarly situated 4 employees of Defendants in the State of ORDER DENYING PLAINTIFF’S 5 California, MOTION FOR PRELIMINARY APPROVAL OF SETTLEMENT 6 Plaintiffs, AGREEMENT (ECF 272) 7 v.
8 QUEST DIAGNOSTICS CLINICAL LABORATORIES, INC., et al., 9 Defendants. 10
11 Plaintiff Pamela Stewart seeks preliminary approval of a settlement agreement 12 regarding her class-action lawsuit and Private Attorney General Act representative action. 13 (ECF 272, at 7.) Before the Court may approve a class-action settlement, it must “certify 14 the class for purposes of judgment on the proposal.” Fed. R. Civ. P. 23(e)(1)(B)(ii). To do 15 so, it must ascertain the class in question. Here, the Court is left guessing as to whether the 16 proposed agreement seeks approval for the previously certified class or one of two new 17 class definitions that plaintiff offers. 18 Stewart acknowledges that this Court previously certified the following class: “All 19 of Defendant’s non-exempt California Patient Service Representatives who were not 20 compensated with one hour of pay for all instances where they did not receive a duty-free 21 and uninterrupted 10-minute rest period consistent with California law, any time between 22 September 13, 2015, and the date of judgment.” (ECF 272, at 10.) She refers to this class 23 in her: (1) motion’s “procedural summary”; (2) attorney’s declaration; (3) settlement 24 agreement; (4) proposed settlement notice; and (5) argument that this “class has previously 25 been certified” and thus that “there is no need to re-establish class certification or request 26 provisional certification.” (Id. at 10, 20; ECF 272-2, at 9, 31, 56.) 27 But elsewhere Stewart defines the class as “All current and former non-exempt 28 Patient Service Representatives of Defendant during the Class Settlement Period.” 1 || (ECF 272, at 7.) She references this class in both the motion’s introduction and the 2 settlement agreement. (/d.; ECF 272-2, at 30.) 3 Finally, Stewart defines a third class in her proposed second amended complaint, 4 ||which accompanies her settlement papers: “All current and former non-exempt Patient 5 ||Service Representatives of Defendant who were employed at any time in the State of 6 California from 4 years from the date of filing this Complaint through the present.” 7 || (ECF 272-2, at 94, 131.) 8 The differences between these three definitions are significant. For example, some 9 || of the proposed classes include only California workers. (ECF 272, at 10, 94.) Another 10 |/includes no geographical limitation to California. (/d. at 7.) And the more recent definitions 11 |/include “[a]ll” non-exempt patient service representatives, while the initially certified 12 || version included only those “who were not compensated with one hour of pay for all 13 ||instances where they did not receive a duty-free and uninterrupted 10-minute rest period.” 14 || (See id. at 7, 10.) 15 Although there is a “strong judicial policy that favors settlements, particularly where 16 || complex class action litigation is concerned,” Class Plaintiffs v. City of Seattle, 955 F.2d 17 || 1268, 1276 (9th Cir. 1992), the Court cannot proceed without a clear class identification, 18 || Fed. R. Civ. P. 23(e)(1)(B)ai). Until then, it cannot determine whether to rely upon its 19 |/previous certification or engage in a “settlement-only class certification” analysis. See 20 ||Amchem Prods., Inc. v. Windsor, 521 U.S. 591, 620 (1997). 21 The motion for preliminary approval of the settlement agreement is thus DENIED 22 || without prejudice. If the parties so choose, they may correct the deficiencies identified in 23 order and submit an amended request no later than April 1, 2025. 24 Dated: February 18, 2025
26 Hon. Andrew G. Schopler 17 United States District Judge 28
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Stewart v. Quest Diagnostics Clinical Laboratories, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/stewart-v-quest-diagnostics-clinical-laboratories-inc-casd-2025.